Related references
Note: Only part of the references are listed.Cardiometabolic Syndrome: An Update on Available Mouse Models
Dimitra Aravani et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Effect of Silymarin Treatment on Circulating Bilirubin and Cardiovascular Disease Risk Factors in Healthy Men: A Single-Blind, Randomized Crossover Trial
Josif Vidimce et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2021)
Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals
Elizabeth M. Williamson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Medicinal plants and bioactive natural compounds as inhibitors ofHMG-CoAreductase: A literature review
Atena Mahdavi et al.
BIOFACTORS (2020)
Health Benefits of Silybum marianum: Phytochemistry, Pharmacology, and Applications
Xin Wang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)
The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction A meta-analysis
Fengyan Xiao et al.
MEDICINE (2020)
Effects of silymarin supplementation on blood lipids: A systematic review and meta-analysis of clinical trials
Hamed Mohammadi et al.
PHYTOTHERAPY RESEARCH (2019)
Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial
Amir Anushiravani et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review
Vahid Soleimani et al.
PHYTOTHERAPY RESEARCH (2019)
Role of silibinin in the management of diabetes mellitus and its complications
Chun Chu et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases
Abdoh Taleb et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Effects of silymarin on metabolic syndrome: a review
Maryam Vahabzadeh et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2018)
Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial
Soraiya Ebrahimpour-koujan et al.
PHYTOMEDICINE (2018)
Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review
Atefeh Tajmohammadi et al.
PHYTOTHERAPY RESEARCH (2018)
The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials
Amir Hadi et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2018)
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Alessandro Federico et al.
MOLECULES (2017)
Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota
Ming Lyu et al.
FRONTIERS IN MICROBIOLOGY (2017)
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis
Chan Wah Kheong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists
Qiuhe Ji
CLINICAL THERAPEUTICS (2017)
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
Angelo A. Izzo et al.
PHYTOTHERAPY RESEARCH (2016)
Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Luminita Voroneanu et al.
JOURNAL OF DIABETES RESEARCH (2016)
Blockade of lipid accumulation by silibinin in adipocytes and zebrafish
Hyung Joo Suh et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases
Vinicyus Teles Chagas et al.
FRONTIERS IN PHARMACOLOGY (2015)
Effect of Addition of Silymarin to Renin-Angiotensin System Inhibitors on Proteinuria in Type 2 Diabetic Patients With Overt Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
Mohammad Kazem Fallahzadeh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Silymarin: A Novel Antioxidant with Antiglycation and Antiinflammatory Properties In Vitro and In Vivo
Chi-Hao Wu et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Hypolipidemic effects of silymarin are not mediated by the peroxisome proliferator-activated receptor alpha
J. Orolin et al.
XENOBIOTICA (2007)
Random-effects model for meta-analysis of clinical trials: An update
Rebecca DerSimonian et al.
CONTEMPORARY CLINICAL TRIALS (2007)
Formulation and biopharmaceutical evaluation of silymarin using SMEDDS
Jong Soo Woo et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
The efficacy of Silybum marianum (L.) Gaertn. (Silymarin) in the treatment of type II diabetes:: A randomized, double-blind, placebo-controlled, clinical trial
H. Fallah Huseini et al.
PHYTOTHERAPY RESEARCH (2006)
Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats
L Sobolová et al.
PHARMACOLOGICAL RESEARCH (2006)
Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high-sucrose diet induced oxidative stress in hereditary hypertriglyceridemic rats
N Skottová et al.
PHARMACOLOGICAL RESEARCH (2004)
Pharmacology of silymarin
F Fraschini et al.
CLINICAL DRUG INVESTIGATION (2002)
Share Paper
